Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

The Independent Data Monitoring Committee met this week on February 10, 2025 to evaluate the unblinded safety Phase 2b QUALITY data and recommended to continue the QUALITY extension study as designed- ...

A recovering ketamine addict from Portsmouth warns of the drug's dangers as use soars among young people. The number treated across the region was an increase on the previous year. The early ...

Authorities said Conley poisoned Yoder, 60, with an anti-inflammatory drug called colchicine. Conley has said she’s innocent.

Patients with debilitating gout are being failed by the NHS because of outdated practices which mean they are prescribed only a third of the medication they need, experts claim.

A woman accused of fatally poisoning her boss had her manslaughter conviction overturned Friday. A New York appeals court ...

The right drawing tablet can make all the difference in bringing your creative vision to life. It should feel like an extension of your hand, translating every brushstroke with precision and fluidity.

We may earn a commission if you make a purchase from the links on this page. Not many manufacturers are still pushing the boundaries in the premium tablet space, but Samsung continues to make waves ...

Colchicine is a medication that has been used for years to treat gout, a condition caused by inflammation from crystal buildup in the joints. The drug is effective at reducing inflammation and ...

The best tablets of 2024 were the new iPad Pro M4 family, Apple's sleek and thin new iPad Pro models. Will 2025 be the year that Android tablets close the gap on Apple's premium tabs? We don't ...

A small tablet can work just as well as (or even better than) larger ones, especially when it comes to lugging one around between classes or in your work bag on your commute. When you're on the ...

In the cited meta-analysis, colchicine was associated with reduced risk of treatment failure (OR: 0.23) and recurrent pericarditis (OR: 0.39), but with a trend toward more adverse effects.